1. Home
  2. PTMN vs EPRX Comparison

PTMN vs EPRX Comparison

Compare PTMN & EPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PTMN
  • EPRX
  • Stock Information
  • Founded
  • PTMN 2006
  • EPRX 2011
  • Country
  • PTMN United States
  • EPRX Canada
  • Employees
  • PTMN N/A
  • EPRX N/A
  • Industry
  • PTMN Finance: Consumer Services
  • EPRX
  • Sector
  • PTMN Finance
  • EPRX
  • Exchange
  • PTMN Nasdaq
  • EPRX NYSE
  • Market Cap
  • PTMN 142.6M
  • EPRX 130.0M
  • IPO Year
  • PTMN N/A
  • EPRX N/A
  • Fundamental
  • Price
  • PTMN $14.08
  • EPRX $3.27
  • Analyst Decision
  • PTMN Hold
  • EPRX Strong Buy
  • Analyst Count
  • PTMN 1
  • EPRX 1
  • Target Price
  • PTMN $16.00
  • EPRX $9.00
  • AVG Volume (30 Days)
  • PTMN 54.0K
  • EPRX 11.5K
  • Earning Date
  • PTMN 05-07-2025
  • EPRX 05-07-2025
  • Dividend Yield
  • PTMN 15.46%
  • EPRX N/A
  • EPS Growth
  • PTMN N/A
  • EPRX N/A
  • EPS
  • PTMN N/A
  • EPRX N/A
  • Revenue
  • PTMN $62,432,000.00
  • EPRX N/A
  • Revenue This Year
  • PTMN N/A
  • EPRX N/A
  • Revenue Next Year
  • PTMN $4.14
  • EPRX N/A
  • P/E Ratio
  • PTMN N/A
  • EPRX N/A
  • Revenue Growth
  • PTMN N/A
  • EPRX N/A
  • 52 Week Low
  • PTMN $13.90
  • EPRX $2.20
  • 52 Week High
  • PTMN $20.84
  • EPRX $4.48
  • Technical
  • Relative Strength Index (RSI)
  • PTMN 16.81
  • EPRX N/A
  • Support Level
  • PTMN $14.30
  • EPRX N/A
  • Resistance Level
  • PTMN $15.69
  • EPRX N/A
  • Average True Range (ATR)
  • PTMN 0.42
  • EPRX 0.00
  • MACD
  • PTMN -0.13
  • EPRX 0.00
  • Stochastic Oscillator
  • PTMN 7.14
  • EPRX 0.00

About PTMN Portman Ridge Finance Corporation

Portman Ridge Finance Corp Inc is a non-diversified closed-end investment company. The company originates, structures, and invests in secured term loans, bonds or notes, and mezzanine debt primarily in privately-held middle market companies but may also invest in other investments such as loans to publicly traded companies, high-yield bonds, and distressed debt securities. The company's investment objective in the Debt securities portfolio is to generate current income and, to a lesser extent, capital appreciation from the investments in senior secured term loans, mezzanine debt, and selected equity investments in privately-held middle market companies.

About EPRX EUPRAXIA PHARMACEUTICALS INC

Eupraxia Pharmaceuticals Inc is a clinical-stage biotechnology company focused on the development of locally delivered, extended-release alternatives to existing pharmaceuticals. Its product EP-104 is used for the treatment of osteoarthritis and eosinophilic esophagitis symptoms. The company leverages its proprietary Diffusphere technology to optimize drug delivery for applications with significant unmet medical needs.

Share on Social Networks: